Céline Valéry

Dr. Céline Valéry


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2021 in Biophysical Reviews
Verified
Journal Article
Closed access
PDF file
PCPriscila Cardoso
Priscila Cardoso
HGHugh Glossop
Hugh Glossop
TMThomas G. Meikle
Thomas G. Meikle
AAArturo Aburto-Medina
Arturo Aburto-Medina
CCCharlotte E. Conn
Charlotte E. Conn
Céline ValéryCéline Valéry
Céline Valéry

1 September 2020 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
JSJamie B. Strachan
Jamie B. Strachan
BDBrendan P. Dyett
Brendan P. Dyett
ZNZeyad Nasa
Zeyad Nasa
Céline ValéryCéline Valéry
Céline Valéry
CCCharlotte E. Conn
Charlotte E. Conn

30 May 2019 in Biomacromolecules
Verified
Journal Article
Closed access
HGHugh D. Glossop
Hugh D. Glossop
GZGayan De zoysa
Gayan De zoysa
YHYacine Hemar
Yacine Hemar
PCPriscila Cardoso
Priscila Cardoso
KWKelvin Wang
Kelvin Wang
VSVijayalekshmi Sarojini
Vijayalekshmi Sarojini

16 June 2017 in Interface Focus
Verified
Journal Article
Open access
DDDurga Dharmadana
Durga Dharmadana
NRNicholas Reynolds
Nicholas Reynolds
CCCharlotte E. Conn
Charlotte E. Conn
Céline ValéryCéline Valéry
Céline Valéry
Amyloid nanofibrils are ubiquitous biological protein fibrous aggregates, with a wide range of either toxic or beneficial activities that are relevant to human disease and normal biology. Protein amyloid fibrillization occurs via nucleated polymerization, through non-covalent interactions. As such, protein nanofibril formation is based on a complex interplay between kinetic and thermodynamic factors. The process entails metastable oligomeric species and a highly thermodynamically favoured end state. The kinetics, and the reaction pathway itself, can be influenced by third party moieties, either molecules or surfaces. Specifically, in the biological context, different classes of biomolecules are known to act as catalysts, inhibitors or modifiers of the generic protein fibrillization process. The biological aggregation modifiers reviewed here include lipid membranes of varying composition, glycosaminoglycans and metal ions, with a final word on xenobiotic compounds. The corresponding molecular interactions are critically analysed and placed in the context of the mechanisms of cytotoxicity of the amyloids involved in diverse pathologies and the non-toxicity of functional amyloids (at least towards their biological host). Finally, the utilization of this knowledge towards the design of bio-inspired and biocompatible nanomaterials is explored.

13 January 2023 in Frontiers in Chemistry
Verified
Journal Article
Open access
PCPriscila Cardoso
Priscila Cardoso
SDSamuel Appiah Danso
Samuel Appiah Danso
AHAndrew Hung
Andrew Hung
CDChaitali Dekiwadia
Chaitali Dekiwadia
NPNimish Pradhan
Nimish Pradhan
Céline ValéryCéline Valéry
Céline Valéry
Microbial resistance to common antibiotics is threatening to cause the next pandemic crisis. In this context, antimicrobial peptides (AMPs) are receiving increased attention as an alternative approach to the traditional small molecule antibiotics. Here, we report the bi-functional rational design of Fmoc-peptides as both antimicrobial and hydrogelator substances. The tetrapeptide Fmoc-WWRR-NH2—termed Priscilicidin—was rationally designed for antimicrobial activity and molecular self-assembly into nanostructured hydrogels. Molecular dynamics simulations predicted Priscilicidin to assemble in water into small oligomers and nanofibrils, through a balance of aromatic stacking, amphiphilicity and electrostatic repulsion. Antimicrobial activity prediction databases supported a strong antimicrobial motif via sequence analogy. Experimentally, this ultrashort sequence showed a remarkable hydrogel forming capacity, combined to a potent antibacterial and antifungal activity, including against multidrug resistant strains. Using a set of biophysical and microbiology techniques, the peptide was shown to self-assemble into viscoelastic hydrogels, as a result of assembly into nanostructured hexagonal mesophases. To further test the molecular design approach, the Priscilicidin sequence was modified to include a proline turn—Fmoc-WPWRR-NH2, termed P-Priscilicidin–expected to disrupt the supramolecular assembly into nanofibrils, while predicted to retain antimicrobial activity. Experiments showed P-Priscilicidin self-assembly to be effectively hindered by the presence of a proline turn, resulting in liquid samples of low viscosity. However, assembly into small oligomers and nanofibril precursors were evidenced. Our results augur well for fast, adaptable, and cost-efficient antimicrobial peptide design with programmable physicochemical properties.

15 August 2018 in Nanoscale
Verified
Journal Article
Closed access
PDF file
DDDurga Dharmadana
Durga Dharmadana
NRNicholas Reynolds
Nicholas Reynolds
CDChaitali Dekiwadia
Chaitali Dekiwadia
CCCharlotte E. Conn
Charlotte E. Conn
Céline ValéryCéline Valéry
Céline Valéry
Amyloid nanofibrils are β-sheet rich protein or peptide assemblies that have pathological roles in over 20 neurodegenerative diseases, but also can have essential physiological roles. This wide variety of functions is likely to be due to subtle differences in amyloid structure and assembly mechanisms. Glycosaminoglycans (GAGs), like heparin, are frequently used in vitro to increase the kinetics of assembly of amyloid fibrils. However, little is known about the effects of adding large polymeric sugars on assembly mechanisms and amyloid nanostructures. Here, we provide insights into the kinetics, assembly mechanisms and structural effects of heparin on the self-assembly of a functional-amyloid forming neuropeptide hormone, somatostatin-14. We show that pure somatostatin-14 self-assembles into amyloid fibrils via the formation of antiparallel β-sheet networks, in a typical amyloid aggregation process. These fibrils then laterally assemble into ordered liquid crystalline structures through the generation of further parallel β-sheet networks. If heparin molecules are present, they intercalate between the peptide assemblies during the initial stages of aggregation. This intercalation screens electrostatic repulsions hindering the lateral association of protofilaments, preventing liquid crystal formation and resulting in the rapid formation of disordered micron scale precipitates. Our results show that aggregation promotors like heparin can have large effects not just on the kinetics of aggregation but also on assembly mechanisms, and the architecture of amyloid assemblies. Thus highlighting the dangers of using such polymeric sugars in fundamental studies of amyloid aggregation, especially when drawing conclusions on structure-function relationships or when investigating amyloid-based nanostructures as bionanomaterials.